David C. Dale
Impact in
- Oncology top 0.1%
- Neutropenia and Cancer Infections
- Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation
Papers in
- Co-authors
- Gary H. LymanSheldon WolffJeffrey CrawfordAnthony S. FauciMichael J. ChusidBurton C. WestLaurence A. BoxerNicole M. Kuderer
- Journals
- Blood (89 papers)Journal of Clinical Oncology (21 papers)Current Opinion in Hematology (13 papers)Journal of Clinical Investigation (12 papers)British Journal of Haematology (10 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
David C. Dale
322 papers receiving 18.5k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Oncology 8.3k
- Hematology 3.3k
- Immunology 6.2k
- Genetics 7.1k
- Emergency Medicine 1.7k
Countries citing papers authored by David C. Dale
This map shows the geographic impact of David C. Dale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Dale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Dale more than expected).
Fields of papers citing papers by David C. Dale
This network shows the impact of papers produced by David C. Dale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Dale. The network helps show where David C. Dale may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Dale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2022 | 11 | |
| 3 | 2022 | 0 | |
| 4 | 2021 | 24 | |
| 5 | 2018 | 9 | |
| 6 | 2017 | 49 | |
| 7 | 2015 | 12 | |
| 8 | 2010 | 111 | |
| 9 | 2005 | 61 | |
| 10 | 2003 | 34 | |
| 11 | Alpha Omega Alpha: encouraging excellence in medicine for more than a century. | 2002 | 1 |
| 12 | 2000 | 18 | |
| 13 | 2000 | 52 | |
| 14 | 1999 | 1 | |
| 15 | 1999 | 3 | |
| 16 | 1999 | 1 | |
| 17 | 1994 | 36 | |
| 18 | 1994 | 164 | |
| 19 | 1994 | 30 | |
| 20 | 1991 | 78 |
About David C. Dale
David C. Dale is a scholar working on Genetics, Oncology, Immunology, Emergency Medicine and Hematology, having authored 337 papers that have together received 19.6k indexed citations. Recurring topics across this work include Blood disorders and treatments (195 papers), Neutropenia and Cancer Infections (166 papers), Immunodeficiency and Autoimmune Disorders (61 papers), Hematological disorders and diagnostics (43 papers), Erythrocyte Function and Pathophysiology (33 papers), Cancer Treatment and Pharmacology (28 papers), Immune Response and Inflammation (22 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (21 papers). The work is most often cited by research in Oncology (8.3k citations), Hematology (3.3k citations), Immunology (6.2k citations), Genetics (7.1k citations) and Emergency Medicine (1.7k citations). David C. Dale has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Gary H. Lyman, Sheldon Wolff, Jeffrey Crawford, Anthony S. Fauci, Michael J. Chusid, Burton C. West, Laurence A. Boxer, Nicole M. Kuderer, W. Conrad Liles and Karl Welte. Their work appears in journals such as Blood, Journal of Clinical Oncology, Current Opinion in Hematology, Journal of Clinical Investigation and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.